JP2019516375A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516375A5
JP2019516375A5 JP2018560186A JP2018560186A JP2019516375A5 JP 2019516375 A5 JP2019516375 A5 JP 2019516375A5 JP 2018560186 A JP2018560186 A JP 2018560186A JP 2018560186 A JP2018560186 A JP 2018560186A JP 2019516375 A5 JP2019516375 A5 JP 2019516375A5
Authority
JP
Japan
Prior art keywords
allele
pos
nuclear position
snp
nuclear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018560186A
Other languages
English (en)
Japanese (ja)
Other versions
JP7475811B2 (ja
JP2019516375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/033625 external-priority patent/WO2017201461A1/en
Publication of JP2019516375A publication Critical patent/JP2019516375A/ja
Publication of JP2019516375A5 publication Critical patent/JP2019516375A5/ja
Priority to JP2022044738A priority Critical patent/JP7392020B2/ja
Priority to JP2023213224A priority patent/JP2024037945A/ja
Application granted granted Critical
Publication of JP7475811B2 publication Critical patent/JP7475811B2/ja
Priority to JP2025203084A priority patent/JP2026048696A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018560186A 2016-05-20 2017-05-19 遺伝子に基づく炎症性腸疾患の診断 Active JP7475811B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022044738A JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断
JP2025203084A JP2026048696A (ja) 2016-05-20 2025-11-25 遺伝子に基づく炎症性腸疾患の診断

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662339357P 2016-05-20 2016-05-20
US62/339,357 2016-05-20
PCT/US2017/033625 WO2017201461A1 (en) 2016-05-20 2017-05-19 Diagnosis of inflammatory bowel disease based on genes

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2022044738A Division JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Division JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断

Publications (3)

Publication Number Publication Date
JP2019516375A JP2019516375A (ja) 2019-06-20
JP2019516375A5 true JP2019516375A5 (https=) 2020-06-18
JP7475811B2 JP7475811B2 (ja) 2024-04-30

Family

ID=60326226

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018560186A Active JP7475811B2 (ja) 2016-05-20 2017-05-19 遺伝子に基づく炎症性腸疾患の診断
JP2022044738A Active JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Pending JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断
JP2025203084A Pending JP2026048696A (ja) 2016-05-20 2025-11-25 遺伝子に基づく炎症性腸疾患の診断

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022044738A Active JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Pending JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断
JP2025203084A Pending JP2026048696A (ja) 2016-05-20 2025-11-25 遺伝子に基づく炎症性腸疾患の診断

Country Status (6)

Country Link
US (2) US11549146B2 (https=)
EP (1) EP3458466B1 (https=)
JP (4) JP7475811B2 (https=)
KR (4) KR102481305B1 (https=)
CN (2) CN109476698B (https=)
WO (1) WO2017201461A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US11186872B2 (en) 2016-03-17 2021-11-30 Cedars-Sinai Medical Center Methods of diagnosing inflammatory bowel disease through RNASET2
KR102481305B1 (ko) * 2016-05-20 2022-12-26 세다르스-신나이 메디칼 센터 유전자에 기반한 염증성 장 질환의 진단
WO2020112890A1 (en) 2018-11-29 2020-06-04 Cedars-Sinai Medical Center Rnaset2 compositions and methods of treatment therewith
JP2022533956A (ja) 2019-05-14 2022-07-27 プロメテウス バイオサイエンシーズ,インク. Tl1a患者を選択する方法、システム、およびデバイス
CN116322762A (zh) * 2020-06-26 2023-06-23 辉瑞公司 用tl1a抗体治疗炎症性肠病的方法
CA3197828A1 (en) * 2020-11-13 2022-05-19 Laurens Kruidenier Methods, systems, and kits for treatment of inflammatory diseases targeting tl1a
CN115851911B (zh) * 2022-11-25 2025-10-24 南京鼓楼医院 一种用于鉴别狼疮性肾炎的尿液外泌体tsRNA标志物和探针及其应用
EP4646434A2 (en) * 2023-01-06 2025-11-12 Prometheus Biosciences, Inc. Methods of treating inflammatory diseases with combination of tl1a inhibitors and tnf inhibitors
CN121843714A (zh) 2023-08-11 2026-04-10 派拉冈医疗公司 Tl1a结合抗体及使用方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443421A (en) 1982-03-16 1984-04-17 Occidental Chemical Corporation Process for removing particulate impurities from aqueous phosphoric acid
DE3475880D1 (en) 1984-08-27 1989-02-09 Toray Industries Solid-liquid separating apparatus
US5000850A (en) 1986-09-10 1991-03-19 Engelhard Corporation Apparatus for dewatering an aqueous clay suspension
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US7357927B2 (en) 1996-03-12 2008-04-15 Human Genome Sciences, Inc. Death domain containing receptors
EP1100962A1 (en) 1998-07-25 2001-05-23 AstraZeneca AB Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
JP2004194534A (ja) 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
CA2541138A1 (en) * 2003-10-06 2005-05-06 Novartis Ag Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease
EP1815021A2 (en) 2004-11-03 2007-08-08 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
CN102321174B (zh) 2005-05-06 2013-10-16 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
US20090317388A1 (en) 2005-05-25 2009-12-24 Linda Burkly Tl1a in treatment of disease
EP1963534A2 (en) * 2005-12-19 2008-09-03 Genizon Biosciences Inc. Genemap of the human gene associated with crohn's disease
US20090018031A1 (en) 2006-12-07 2009-01-15 Switchgear Genomics Transcriptional regulatory elements of biological pathways tools, and methods
US20110217310A1 (en) 2007-01-10 2011-09-08 Siegel Richard M Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
CA2676227A1 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
WO2008106451A2 (en) 2007-02-26 2008-09-04 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
US20100055700A1 (en) 2007-02-28 2010-03-04 Cedars-Sinai Medical Center Role of il-12, il-23 and il-17 receptors in inflammatory bowel disease
US20150376707A1 (en) * 2007-05-18 2015-12-31 Cedars-Sinai Medical Center Methods of diagnosing and treating inflammatory bowel disease
US8118175B2 (en) 2007-07-18 2012-02-21 Siemens Industry, Inc. Venting device for a disc filter
WO2009039244A2 (en) * 2007-09-18 2009-03-26 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
US20100240043A1 (en) * 2007-10-19 2010-09-23 Cedars-Sinai Medical Center Methods of using genetic variants to diagnose and predict inflammatory bowel disease
UA104132C2 (en) 2007-11-13 2014-01-10 Тева Биофармасьютикалз Юесей, Инк. Humanized antibodies against tl1a
ME01898B (me) 2008-08-12 2014-12-20 Zinfandel Pharmaceuticals Inc Metoda za identifikaciju faktora rizika od alchajmerove bolesti
RU2011111748A (ru) 2008-08-29 2012-10-10 Сентокор Орто Байотек Инк. (Us) Маркеты и способы анализа и лечения язвенного колита и сходных заболеваний с использованием панели из 20 генов
JP2010088432A (ja) 2008-09-09 2010-04-22 Kansetsu Saisei Kenkyusho:Kk Tnf阻害薬治療による有効性・副作用発現に関する多型、およびその利用
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
CA2758531C (en) 2009-04-14 2018-11-13 Derren Barken Inflammatory bowel disease prognostics
US20130136720A1 (en) 2010-01-15 2013-05-30 Cedars-Sinai Medical Center Methods of using fut2 genetic variants to diagnose crohn's disease
CA2801575A1 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis
US8766034B2 (en) 2010-09-22 2014-07-01 Cedars-Sinai Medical Center TL1A model of inflammation fibrosis and autoimmunity
EP3260540A1 (en) 2010-11-12 2017-12-27 The General Hospital Corporation Polycomb-associated non-coding rnas
US9902996B2 (en) * 2011-02-11 2018-02-27 Cedars-Sinai Medical Center Methods of predicting the need for surgery in crohn's disease
JP2014517279A (ja) 2011-05-10 2014-07-17 ネステク ソシエテ アノニム 個別治療管理のための疾患活動性プロファイリングの方法
WO2012156515A1 (en) 2011-05-18 2012-11-22 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of acute myeloid leukemia
KR20140104344A (ko) 2011-05-20 2014-08-28 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 시크리터리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시스 T 세포 매개성 질병의 병증을 개선하기 위한 tl1a-dr3의 상호작용의 차단 및 그것의 항체
SG195253A1 (en) 2011-06-03 2013-12-30 Xoma Technology Ltd Antibodies specific for tgf-beta
SG11201401536QA (en) 2011-10-21 2014-05-29 Nestec Sa Methods for improving inflammatory bowel disease diagnosis
WO2013117751A2 (en) 2012-02-10 2013-08-15 Novo Nordisk A/S Methods related to treatment of inflammatory diseases and disorders
KR102343212B1 (ko) 2013-03-27 2021-12-23 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
WO2014186750A2 (en) 2013-05-17 2014-11-20 Cedars-Sinai Medical Center Variants of tnfsf15 and dcr3 associated with crohn's disease
PT3054977T (pt) * 2013-10-09 2021-10-14 Cedars Sinai Medical Center Diagnóstico e tratamento da síndrome do intestino irritável e da doença inflamatória intestinal
US11365447B2 (en) 2014-03-13 2022-06-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3286318A2 (en) 2015-04-22 2018-02-28 Mina Therapeutics Limited Sarna compositions and methods of use
IL261228B2 (en) 2016-02-26 2023-12-01 Nanotech Energy Inc Methods, devices and systems for processing preparations containing carbon
KR102481305B1 (ko) 2016-05-20 2022-12-26 세다르스-신나이 메디칼 센터 유전자에 기반한 염증성 장 질환의 진단
US10041044B2 (en) 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
MY191324A (en) 2016-10-26 2022-06-15 Cedars Sinai Medical Center Neutralizing anti-tl1a monoclonal antibodies
WO2018204764A1 (en) 2017-05-05 2018-11-08 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
US11675142B2 (en) 2018-12-14 2023-06-13 Fujikura Ltd. Ferrule, fiber-equipped ferrule, and method for manufacturing fiber-equipped ferrule

Similar Documents

Publication Publication Date Title
JP2019516375A5 (https=)
JP2012080900A5 (https=)
JP2012503985A5 (https=)
JP2018038436A5 (https=)
WO2007130519A3 (en) Viral nucleic acid microarray and method of use
JP2009528060A5 (https=)
JP2016041070A5 (https=)
JP2017507130A5 (https=)
CA2938731A1 (en) Methods of treating alzheimer's disease
JP2010529857A5 (https=)
JP2013532494A5 (https=)
JP2008526249A5 (https=)
JP2014533949A5 (https=)
JP2011528903A5 (https=)
JP2010528590A5 (https=)
JP2013544536A5 (https=)
JP2021511075A (ja) 癌におけるマイクロサテライト不安定性を検出するためのバイオマーカーパネル及び方法
US20150011415A1 (en) Method for calculating a disease risk score
JP2009526524A5 (https=)
Schorderet et al. IROme, a New High‐Throughput Molecular Tool for the Diagnosis of Inherited Retinal Dystrophies
JP2011530312A5 (https=)
JP2011502510A5 (https=)
Jauset-Rubio et al. Solid-phase primer elongation using biotinylated dNTPs for the detection of a single nucleotide polymorphism from a fingerprick blood sample
KR101287431B1 (ko) 표적 유전자의 다양한 변이가 존재하는 유전자 영역을 증폭하기 위한 프라이머 조성물, 이를 이용한 표적 유전자 증폭 방법 및 이를 포함하는 pcr 증폭 키트 그리고 이를 이용한 표적 유전자의 유전자형 분석방법
JP2008306974A (ja) Hcv遺伝子型判定方法、並びに、これに用いるlnaプローブ及びキット